Test Directory
| Test Code | ||||
| VRCZS | ||||
| Test Name | ||||
| Voriconazole, Serum | ||||
| CPT Codes | ||||
| 80285 | ||||
| Expected Turnaround Time | ||||
| 1 - 2 day | ||||
| Clinical Utility | ||||
|
Monitoring trough levels of voriconazole is suggested for: -Individuals with reduced liver function -Individuals with cytochrome P450 (CYP) 2C19 alterations associated with poor metabolic function -Patients taking other medications that affect CYP2C19 activity -Patients experiencing potential toxicity Monitoring trough levels may be reasonable in patients who are not responding optimally or have drug interactions that may decrease voriconazole levels or to ensure adequate oral absorption |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Serum
Collection Container: Red Top, Plain Desired Specimen Volume: 2 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Liquid Chromatography - Tandem Mass Spectrometry (Lc/Ms/Ms) | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Limitations | ||||
|
Voriconazole metabolism may be altered by coadministration of drugs that metabolically induce or inhibit cytochrome P450 2C19 or by genetic alterations that affect enzyme activity. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| Mayo Clinic Laboratories | ||||
| Testing Schedule | ||||
| Routine, daily | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.